132 related articles for article (PubMed ID: 17846144)
1. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.
Lacy MK; Lu W; Xu X; Tessier PR; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1999 Mar; 43(3):672-7. PubMed ID: 10049286
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of fluoroquinolone resistance is an important factor in determining the antimicrobial effect of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.
MacGowan AP; Bowker KE
Antimicrob Agents Chemother; 2003 Mar; 47(3):1096-100. PubMed ID: 12604547
[TBL] [Abstract][Full Text] [Related]
4. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.
Kriengkauykiat J; Porter E; Lomovskaya O; Wong-Beringer A
Antimicrob Agents Chemother; 2005 Feb; 49(2):565-70. PubMed ID: 15673734
[TBL] [Abstract][Full Text] [Related]
5. Host Cell Oxidative Stress Promotes Intracellular Fluoroquinolone Persisters of Streptococcus pneumoniae.
Hernandez-Morfa M; Reinoso-Vizcaíno NM; Olivero NB; Zappia VE; Cortes PR; Jaime A; Echenique J
Microbiol Spectr; 2022 Dec; 10(6):e0436422. PubMed ID: 36445159
[TBL] [Abstract][Full Text] [Related]
6. Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis.
Gould CV; Sniegowski PD; Shchepetov M; Metlay JP; Weiser JN
Antimicrob Agents Chemother; 2007 Sep; 51(9):3225-9. PubMed ID: 17664329
[TBL] [Abstract][Full Text] [Related]
7. Efflux pump effects on levofloxacin resistance in
Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
[No Abstract] [Full Text] [Related]
8. Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to
Alvarado M; Martín-Galiano AJ; Ferrándiz MJ; Zaballos Á; de la Campa AG
Front Microbiol; 2017; 8():2074. PubMed ID: 29123510
[TBL] [Abstract][Full Text] [Related]
9.
Dao TH; Echlin H; McKnight A; Marr ES; Junker J; Jia Q; Hayden R; van Opijnen T; Isberg RR; Cooper VS; Rosch JW
mBio; 2024 Feb; 15(2):e0282823. PubMed ID: 38193698
[No Abstract] [Full Text] [Related]
10. Multi-drug resistance pattern and genome-wide SNP detection in levofloxacin-resistant uropathogenic Escherichia coli strains.
Okumura K; Kaido M; Muratani T; Yamasaki E; Akai Y; Kurazono H; Yamamoto S
Int J Urol; 2024 Mar; 31(3):295-300. PubMed ID: 38041251
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing fluoroquinolone resistance.
Sahm DF; Thornsberry C; Jones ME; Karlowsky JA
Emerg Infect Dis; 2003 Dec; 9(12):1651-4. PubMed ID: 14725310
[No Abstract] [Full Text] [Related]
12. Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect.
Ambrose PG; VanScoy BD; Luna BM; Yan J; Ulhaq A; Nielsen TB; Rudin S; Hujer K; Bonomo RA; Actis L; Skaar E; Spellberg B
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782989
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis Gene Expression Associated With Fluoroquinolone Resistance and Efflux Pump Inhibition.
van der Heijden YF; Maruri F; Blackman A; Morrison R; Guo Y; Sterling TR
J Infect Dis; 2023 Aug; 228(4):469-478. PubMed ID: 37079382
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Delafloxacin against a Burkholderia pseudomallei Efflux Mutant Panel.
McCurdy SP; Somprasong N; Schweizer HP
Microbiol Spectr; 2022 Oct; 10(5):e0090322. PubMed ID: 35972245
[No Abstract] [Full Text] [Related]
15. The Drug-Specific Propensity Regarding the Acquisition of Fluoroquinolone Resistance in
Sato T; Ito R; Kawamura M; Fujimura S
Infect Drug Resist; 2023; 16():6357-6366. PubMed ID: 37789839
[TBL] [Abstract][Full Text] [Related]
16. Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds.
Rakic-Martinez M; Drevets DA; Dutta V; Katic V; Kathariou S
Appl Environ Microbiol; 2011 Dec; 77(24):8714-21. PubMed ID: 22003016
[TBL] [Abstract][Full Text] [Related]
17. Role of the Two-Component System CiaRH in the Regulation of Efflux Pump SatAB and Its Correlation with Fluoroquinolone Susceptibility.
Yang X; Peng W; Wang N; Dou B; Yang F; Chen H; Yuan F; Bei W
Microbiol Spectr; 2022 Jun; 10(3):e0041722. PubMed ID: 35638854
[TBL] [Abstract][Full Text] [Related]
18. Enhancing bactericidal activities of ciprofloxacin by targeting the trans-translation system that is involved in stress responses in Klebsiella pneumoniae.
Fang W; Xu J; Wei Z; Wu J; Wu W; Wang Y; Chen S
Arch Microbiol; 2024 Mar; 206(4):154. PubMed ID: 38478112
[TBL] [Abstract][Full Text] [Related]
19. A novel gene amplification causes upregulation of the PatAB ABC transporter and fluoroquinolone resistance in Streptococcus pneumoniae.
Baylay AJ; Ivens A; Piddock LJ
Antimicrob Agents Chemother; 2015; 59(6):3098-108. PubMed ID: 25779578
[TBL] [Abstract][Full Text] [Related]
20. Role of Efflux Pumps in the
Jiang X; Yu T; Xu P; Xu X; Ji S; Gao W; Shi L
Front Microbiol; 2018; 9():2350. PubMed ID: 30319598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
